Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
Kaiser Permanente
AstraZeneca
Context Therapeutics Inc.
BioNTech SE
Jonsson Comprehensive Cancer Center
University of Nebraska
University of Southern California
West China Hospital
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Arizona
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
University Medical Center Groningen
Seagen Inc.
Astellas Pharma Inc
DxTerity Diagnostics
Second Affiliated Hospital of Guangzhou Medical University
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
SpeciCare
Jonsson Comprehensive Cancer Center
Abramson Cancer Center at Penn Medicine
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
CureOne
Children's Oncology Group
Children's Oncology Group
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
City of Hope Medical Center
Rutgers, The State University of New Jersey